$TSLA had one of the most volatile weeks I've seen in years. It printed alternating green and red days with 20 pt moves up and down each day. By Friday we saw TSLA close at a key resistance at 440. Delivery numbers coming this week + ATH on the horizon. Here's my plan 👇 Trigger: $TSLA above 440 ✅ Trade idea: TSLA Oct 3 455C Targets: 456,465 🎯 TSLA touched 444 on Monday, dipped to 423 on Tuesday, then 419 by Thursday and reversed to 440 by Friday. It's in a tight range here above 419. If TSLA can continue to defend 430 we can see a run to 465+ by early October. Delivery numbers should be coming by Wednesday/Thursday. TSLA to 488-500 possible by next month.
📊🧮⚖️ Large Caps Have Never Looked Less Attractive: $SPX ⚠️🧯🔎
$S&P 500(.SPX)$$ISHARES S&P MID-CAP ETF/AUS(IJH.AU)$$Invesco S&P 500 Equal Weight ETF(RSP)$ I’m keeping this simple. The spread in forward P/E between U.S. large caps and SMID caps has blown out again. As of 26Sep25, the S&P 500 sits near 22.5× forward earnings while the S&P 400 and S&P 600 are nearer 17.1× and 16.6×. That’s a double-digit multiple premium for size rather than for quality. The Yardeni-style chart makes it obvious; large caps have rerated while SMID has not. 🧩 Why that matters The JPM data frames it perfectly: the 30-year average forward P/E is 17.0×. Today’s 22.5× means investors are paying a 30%+ premium to history. Ad
$AEM SGD(AWX.SI)$ She is echoing the same lifeline for Intel as Intel is their major customer! The company may see more revenue stream coming back from Intel if their foundry operations get an improve version to compete with others! Short term wise, the price has Gapped up and running up for a few days due to this piece of news, it may continue to trend higher for a short while before reality set in. Chart wise, bullish mode! After hitting the high of 1.96, she is taking a breather. Let's see if this bullish momentum continue! The share price has gained more than 20% from 1.50+ to 1.81. She may rise up to test 1.92 than 1.96. A nice breakout smoothly plus high volume we may see her rising up further towards 2.00 and above! Pls dyod
That's an interesting approach, founder-led companies. I guess the results do speak for themselves. I didn't really follow her trades but I heard she sold some Tesla in around May or June. Prices weren't that high back then. Recently when it hit 440 plus, I sold my Tesla thinking that maybe it's time to sell since Cathie Wood sold too. Maybe if she buys Tesla again, I may consider following.
I personally don't believe in Intel's revenge comeback. I think it's a short term media fuelled rush to get on the boat. Even if other giants team up with Intel, I think the price will drop when the hype is over unless they really produce good results. Intel had always been unable to keep up with its highs. The higher it goes, the faster it drops. Instead of jumping into the boat, maybe shorting could be another option for speculative traders.
Here is a structured view of the situation, along with my views and a tentative tactical posture. (These are not investment recommendations, but rather a reasoned framework.) --- 1. Is this a “healthy” pullback? In my view, yes — and in fact I would prefer to see occasional corrective pressures in such a stretched market. Here’s why I lean that way: Supporting arguments for a healthy pullback Overbought conditions: The U.S. equity market has run strongly through September (helped by the Fed’s rate cut). At some point, profit-taking and trimming become natural. Valuation introspection: With many valuation metrics at (or near) extremes, a modest pullback helps “reset” investor expectations. Technical/composure: A shallow, controlled decline (say 3%–5%) is often healthier than letting sentime
For most retail investors managing under US $100,000, the priority should be capital preservation and consistent compounding, not trying to outsmart hedge funds or algorithmic traders. The key lies in adopting disciplined, rule-based mindsets rather than chasing market timing. --- 1. What Retail Investors Should Focus On a. Build a Sound Foundation Diversify prudently: Hold a mix of equities, ETFs, and perhaps a small bond or cash component to smooth volatility. Use dollar-cost averaging: Investing a fixed amount monthly helps reduce timing risk and lowers the average cost per share. Focus on low-cost instruments: Minimise fees through ETFs or index funds — small cost savings compound significantly. b. Prioritise Risk Management Limit exposure per position: Never risk more than 5–10 % of t
When The Rally Pauses: Hedging Hope In A High Valuation Market
🌟🌟🌟The US market saw 3 days of red, 1 day of green. It has just danced through a week of emotional whiplash, rising Friday after a cooler inflation print but still closing the week lower. The S&P500, Nasdaq and the Dow Jones Indexes all gave back their post Fed September meeting gains. Jerome Powell's words linger like a warning bell: "Stocks are fairly highly valued". Suddenly, the exuberance that defined 2025 feels fragile. Strong economic data, once a source of comfort, now casts doubt on the Fed's rate cut path. Tech Giants - those symbols of innovation and comfort are stumbling. Nvidia, Oracle and even Tesla have lost their shine. Is this a healthy pullback? Or is it the market's way of asking - Can earnings justify the hype?
📅 Next Week’s Market Outlook: Volatile Rebound or Bull Trap?
$Circle Internet Corp.(CRCL)$ $Rezolve AI(RZLV)$ $Eightco Holdings Inc.(ORBS)$ 🏦 Macro Factors to Watch for 29 Sep to 3 Oct 1. Fed Rate Cut Fallout: The recent rate cut will likely prop up liquidity-sensitive assets. However, recession fears may creep back into the narrative. Expect early-week optimism, but watch for mid-week profit-taking. 2. October Seasonality: Historically, early October sees choppy price action before a stronger Q4 rally. This could mean false breakouts early in the week. 3. Key Data Ahead: US ISM Manufacturing (Oct 1): Will test the strength of industrial rebound. Non-Farm Payrolls (Oct 4): A weak print = bullish for rate cut
Cathie Wood’s Innovation Bets — Ready to Rise Again in 2025?
Cathie Wood is no stranger to bold, futuristic calls. As the head of ARK Invest, she's poured billions into disruptive tech—AI, robotics, genomics, and crypto. Her strategy? Don't just chase profits—bet on paradigm shifts. 🔍 But after a wild ride from 2020 to 2024, where does $ARKK go from here? Here's what we see heading into late 2025: 🚀 Rate cuts = innovation rebound. With interest rates finally turning lower, the pressure on unprofitable growth stocks is easing. That'e bullish for names like: $TSLA (Tesla) – EV margins are recovering, and FSD expansion is back in the spotlight. $ROKU – Cathie's long-time favorite, likely to benefit from increased ad-tech and streaming growth. $COIN (Coinbase) – Positioned to ride the next wave of crypto adoption amid ETF approvals. 📈 ARKK's upside
🇸🇬 October 2025 Dividend Calendar - Which SGX Payouts Are Actually Worth Your Money? | 🦖 #TheInvestingIguana EP1015
🟩📈 Looking for October's top dividend stocks? Join Iggy from the Investing Iguana as we dive into Singapore's October 2025 dividend landscape, shedding light on the best payouts and steering clear of risky traps! Packed with insights, this video reveals the top 3 dividend picks—SGX, S, and BRC Asia—breaking down why they shine and how they fit into a long-term investment strategy. Whether you're eyeing stability, growth, or steady income, this guide has you covered. 🦎 Learn how to build a portfolio that balances security and opportunity while sidestepping high-yield traps, risky sectors, and forex headaches. With expert financial analysis and actionable tips, this video is your roadmap to smarter investment decisions this month. Remember, investing is a long-term game. Be patient, discipli
When a company released its financial report, how do we determine if it's good or bad? There are many indicators to consider, but we can simplify and focus on the following 4 key points. 1. Revenue growth The absolute value of the revenue growth rate may be a reliable indicator to help determine a company's growth momentum. The higher the growth rate compared to its peers in the industry, the more significant the company's growth potential. 2. Net income growth The absolute value of the net income growth rate is another key variable to consider when evaluating a company's growth. Moreover, it's important to compare the net income growth to that of revenue. If the net income growth rate exceeds the revenue growth rate, it suggests that the company is becoming increasingly pr
Retail Investing 101: The Art Of Growing My Portfolio
🌟🌟🌟Investing can be an art and a science for small retail investors like me. The Art : This is where intuition, storytelling and emotion come in. We fall in love with business models, admire founders who defy odds and sometimes buy a stock because it feels like us - plucky, visionary and quietly powerful. We hold through storms not because of charts but because of our conviction. The Science : This is the discipline. The compounding maths. The quarterly earnings. The asset allocation. The rebalancing. The boring bits that quietly build wealth while we sleep. It is the part that says "Don't chase. Don't panic. Don't YOLO into meme stocks because your best friend says it is the next Tesla." The Magic : When art and scien
📉 Market Down 3 Days! Valuations Too High: Time to Hedge or Stay the Course? 🚀 Introduction – From Euphoria to Anxiety in 72 Hours It only takes a few red days to shift market sentiment. After three straight sessions of declines, U.S. stocks have erased their post-Fed September gains. The S&P 500, Nasdaq, and Dow all pulled back, with tech giants leading the weakness. Why the sudden change? Powell’s warning that equities look “quite high by many measures” still lingers. Stronger economic data muddied the outlook for future rate cuts. Valuations stretched: Price-to-earnings ratios remain well above historical averages. So the question for investors is timely: Is this just a healthy pullback… or a signal to hedge portfolios against deeper risk? --- 1️⃣ The Bearish View – Valuations Too H
🏢 Centurion REIT Soars 9.1%! Is Singapore’s IPO Market Back on Track? 🚀 Introduction – A Rare Pop in SGX IPOs Singapore’s IPO market has been relatively quiet in recent years, but Centurion Accommodation REIT just made noise with a $599 million IPO — the second-largest listing of 2025. Shares surged 9.1% at debut, making it one of the few REITs in recent memory to deliver a strong first-day performance. This single listing helped drive Singapore’s total IPO fundraising to $1.4 billion in 2025 — the highest in six years. For investors, the question is clear: Is this the start of a new wave of momentum for SGX IPOs and REITs, or just a one-off success? --- 1️⃣ Why Centurion REIT Stood Out Scale: $599 million raised — significant in the Singapore context. Demand: Strong institutional and reta
I’ve always admired Cathie Wood’s conviction in innovation-focused investing. Her emphasis on founder-led companies resonates with me since vision and execution often come from leaders willing to take bold risks. While many investors stick with big tech, I find her strategy of spotting “pure beneficiaries” of innovation refreshing, even if it’s volatile. I’ve followed some of ARK’s trades before, and the ride wasn’t always smooth. The drawdowns can be tough, but I value her discipline in rebalancing and long-term mindset. This style requires patience and conviction—it’s not for everyone, but it helps me think beyond short-term results. If I had to pick between Cathie Wood and Nancy Pelosi as a “queen of stocks,” I’d lean toward Cathie. She’s not always right, but her commitment to disrupt
Singapore’s “Buffett” Dinner 💸 S$18,900 for a Meal – Would You Do It?
What does S$18,900 buy you in Singapore? A luxury stay? A small art collection? For wealth manager Ng Tse Meng, it bought something far rarer: a private dinner with DBS’s new female CEO, Tan Su Shan. Imagine sitting across from one of the most powerful figures in Singapore’s banking world. This isn’t about food, it’s about ideas and perspective. The kind of conversation that could reshape how you see business, leadership, and opportunities. I’m not rich so spending S$18,900 on a meal isn’t even on my radar. But if I were wealthy, the decision would be different. Money isn’t the real barrier here. If I were very wealthy, S$18,900 would be small change, and the opportunity cost in dollars would be negligible. The bigger consideration is whether I have the mental space and hours to fully enga
$Occidental(OXY)$$WTI Crude Oil - main 2511(CLmain)$$Chevron(CVX)$ 🔥💰📊 Occidental’s $10B OxyChem Exit: Debt Reset or Full Transformation? 🚨⚡️📈 I’m convinced Occidental Petroleum is standing at one of the most pivotal moments in its history. A $10B+ OxyChem sale, coupled with relentless debt reduction and a bullish technical structure, is more than housekeeping. It’s a statement of intent. Backed by Buffett, OXY is deliberately reshaping its future and positioning itself for the next commodity cycle with sharper focus and stronger capital discipline. 💰 A Major Portfolio Shift Occidental Petroleum ($OXY) is reportedly close to selling its OxyChem unit for $10B+
$Leslie's, Inc.(LESL)$$Cemtrex(CETX)$$Erayak Power Solution Group Inc.(RAYA)$ 🔥📉🔄 Reverse Splits Take Centre Stage This Week 🔄📉🔥 💡 The landscape between 29Sep25 and 03Oct25 is dominated by reverse splits, a move most companies reserve as a last line of defence. Let’s unpack the lineup and what it really signals beneath the surface. 📊 This Week’s Confirmed Splits • Leslie’s $LESL: 1-for-20 reverse split effective 29Sep25 • Cemtrex $CETX: 1-for-15 reverse split effective 29Sep25 • Lunai Bioworks $LUNAI: 10-for-1 reverse split effective 30Sep25 • Erayak Power $RAYA: 220-for-1 reverse split effective 30Sep25 • Predictive Oncology $POAI: 1-for-15 reverse split effec
$Nike(NKE)$ is expected to report its fiscal Q1 2026 earnings on Tuesday, September 30, 2025, after the market close. The general consensus points to a challenging quarter, largely due to management's "Win Now" turnaround strategy and external macroeconomic pressures. Summary Write-up of Nike (NKE) Fiscal Q4 2025 Earnings Nike reported its fiscal fourth quarter (Q4) 2025 earnings which, while showing significant year-over-year declines, surpassed analysts' lowered expectations for both revenue and earnings per share (EPS). The quarter, which ended May 31, 2025, was described by management as a transitional and "bottoming-out" point in the company's "Win Now" transformation strategy. Key Financial Highlights (Q4 FY2025 vs. Q4 FY2024): Revenue: $11.1